Clinical Trials
68 trialsTesting Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors
Pediatric Brain Tumor Consortium
MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation
M.D. Anderson Cancer Center
MENTHE
Fondation Ophtalmologique Adolphe de Rothschild
Study of Stored Tumor Samples in Young Patients With Brain Tumors
St. Jude Children's Research Hospital
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
Dartmouth-Hitchcock Medical Center
18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain
Mayo Clinic
PEAR-GLIO
Ourotech, Inc.
Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
University of Michigan Rogel Cancer Center
SPiRiT
Duke University
US Selumetinib Registry
Alexion Pharmaceuticals, Inc.
GBMdexaB
Amsterdam UMC, location VUmc
Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib
Pfizer
Identification of Genomic Changes in Families Having Multiple Members With Tumors
St. Joseph's Hospital and Medical Center, Phoenix
Discerning Pseudoprogression vs True Tumor Growth in GBMs
Ascension Health
Bioenergetic Profiling and Cognition in GBM Patients
Wake Forest University Health Sciences
FORESEE
Biocept, Inc.
A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CCM Blood Biomarker Validation Study
Texas Tech University Health Sciences Center, El Paso
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
University of Nebraska
F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma
Asan Medical Center
CHAT CNS
University of Utah
TuScCom
CENTOGENE GmbH Rostock
Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
University of Wisconsin, Madison
Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
DMBT1
University Hospital, Lille
Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational Phase
University of Minnesota
Medical Treatment Decision Making Using Adaptive Conjoint Analysis
St. Jude Children's Research Hospital
Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors
The Netherlands Cancer Institute
Risk Factors for Adult-Onset Brain Tumors
Vanderbilt University Medical Center
68Ga-citrate PET/MR Imaging for Glioma
University of California, San Francisco
Genetic Analysis of Brain Tumors
National Institutes of Health Clinical Center (CC)
A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes
National Institutes of Health Clinical Center (CC)
Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET
University of Oklahoma
Biomarker Analysis of Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients
United Therapeutics
Methionine and PBR28-PET (Peripheral Benzodiazepine Receptors) in Brain Metastases Following Radiosurgery
Yale University
N1
CureOne
Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
Baylor Research Institute
SPARE
HCA International Limited
Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure
Stanford University
Spectral Analysis Probe to Identify Glioblastoma Cells
University of Oklahoma
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Vanderbilt-Ingram Cancer Center
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
National Institutes of Health Clinical Center (CC)
Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy
Wake Forest University Health Sciences
Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)
University of Florida
Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer
Duke University
IDEPREG
Rigshospitalet, Denmark